Table 2.
Relative Contribution of Tumor Location per Time Period for Malignant Tumors, Pilocytic Astrocytomas, and Nonmalignant Tumors Specified by ICCC-3 Diagnostic Groups
| (IIIa) Ependymomas and Choroid Plexus Tumor | (IIIb) and (IIId) Astrocytomas and Other Gliomas | (IIIc) Intracranial and Intraspinal Embryonal Tumors | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malignant | Nonmalignant | Malignant | Pilocytic Astrocytomas | Nonmalignant | Malignant | ||||||||||||
| 1990-1999 | 2000-2009 | 2010-2017 | 2000-2009 | 2010-2017 | 1990-1999 | 2000-2009 | 2010- 2017 | 1990-1999 | 2000-2009 | 2010-2017 | 2000-2009 | 2010-2017 | 1990-1999 | 2000-2009 | 2010-2017 | ||
| (N = 102) | (N = 104) | (N = 66) | (N = 35) | (N = 33) | (N = 268) | (N = 296) | (N = 275) | (N = 244) | (N = 361) | (N = 280) | (N = 16) | (N = 15) | (N = 190) | (N = 235) | (N = 191) | ||
| (C70.0) Cerebral meninges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| (C70.1) Spinal meninges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| (C70.9) Meninges, NOS | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| (C71.0) Cerebrum | 5 (4.9%) | 2 (1.9%) | — | — | — | 31 (11.6%) | 31 (10.5%) | 29 (10.5%) | 11 (4.5%) | 16 (4.4%) | 27 (9.6%) | 2 (12.5%) | 2 (13.3%) | 1 (0.5%) | 4 (1.7%) | 4 (2.1%) | |
| (C71.1) Frontal lobe | 4 (3.9%) | 10 (9.6%) | 4 (6.1%) | — | — | 27 (10.1%) | 13 (4.4%) | 24 (8.7%) | 2 (0.8%) | 6 (1.7%) | 7 (2.5%) | 3 (18.8%) | 2 (13.3%) | 2 (1.1%) | 13 (5.5%) | 3 (1.6%) | |
| (C71.2) Temporal lobe | 2 (2.0%) | 2 (1.9%) | 1 (1.5%) | — | — | 32 (11.9%) | 29 (9.8%) | 20 (7.3%) | 6 (2.5%) | 12 (3.3%) | 12 (4.3%) | 1 (6.2%) | 2 (13.3%) | — | 9 (3.8%) | 1 (0.5%) | |
| (C71.3) Parietal lobe | 4 (3.9%) | 4 (3.8%) | 1 (1.5%) | — | — | 14 (5.2%) | 13 (4.4%) | 6 (2.2%) | 2 (0.8%) | 10 (2.8%) | 4 (1.4%) | — | — | 5 (2.6%) | 4 (1.7%) | 4 (2.1%) | |
| (C71.4) Occipital lobe | 2 (2.0%) | 3 (2.9%) | 1 (1.5%) | — | — | 4 (1.5%) | 7 (2.4%) | 1 (0.4%) | 2 (0.8%) | 1 (0.3%) | 2 (0.7%) | — | — | 2 (1.1%) | 1 (0.4%) | 2 (1.0%) | |
| (C71.5) Ventricle, NOS | 31 (30.4%) | 29 (27.9%) | 22 (33.3%) | 18 (51.4%) | 18 (54.5%) | 9 (3.4%) | 9 (3.0%) | 11 (4.0%) | 17 (7.0%) | 17 (4.7%) | 15 (5.4%) | 9 (56.2%) | 5 (33.3%) | 15 (7.9%) | 3 (1.3%) | 7 (3.7%) | |
| (C71.6) Cerebellum, NOS | 20 (19.6%) | 7 (6.7%) | 9 (13.6%) | — | — | 25 (9.3%) | 8 (2.7%) | 10 (3.6%) | 93 (38.1%) | 117 (32.4%) | 95 (33.9%) | — | — | 142 (74.7%) | 173 (73.6%) | 150 (78.5%) | |
| (C71.7) Brain stem | 7 (6.9%) | 16 (15.4%) | 10 (15.2%) | — | 1 (3.0%) | 51 (19.0%) | 130 (43.9%) | 127 (46.2%) | 23 (9.4%) | 34 (9.4%) | 33 (11.8%) | — | — | 3 (1.6%) | 8 (3.4%) | 11 (5.8%) | |
| (C71.8) Overlapping lesion of brain | 10 (9.8%) | 12 (11.5%) | 9 (13.6%) | — | — | 47 (17.5%) | 25 (8.4%) | 25 (9.1%) | 15 (6.1%) | 13 (3.6%) | 12 (4.3%) | 1 (6.2%) | 1 (6.7%) | 10 (5.3%) | 13 (5.5%) | 6 (3.1%) | |
| (C71.9) Brain, NOS | 6 (5.9%) | 11 (10.6%) | 2 (3.0%) | — | — | 15 (5.6%) | 13 (4.4%) | 4 (1.5%) | 31 (12.7%) | 34 (9.4%) | 14 (5.0%) | — | 3 (20.0%) | 6 (3.2%) | 6 (2.6%) | 2 (1.0%) | |
| (C72.0) Spinal cord | 11 (10.8%) | 8 (7.7%) | 6 (9.1%) | 14 (40.0%) | 13 (39.4%) | 9 (3.4%) | 15 (5.1%) | 8 (2.9%) | 2 (0.8%) | 12 (3.3%) | 13 (4.6%) | — | — | 3 (1.6%) | 1 (0.4%) | 1 (0.5%) | |
| (C72.1) Cauda equina | — | — | 1 (1.5%) | 3 (8.6%) | 1 (3.0%) | — | — | 1 (0.4%) | — | — | — | — | — | — | — | — | |
| (C72.3) Optic nerve | — | — | — | — | — | 1 (0.4%) | 3 (1.0%) | 9 (3.3%) | 39 (16.0%) | 88 (24.4%) | 46 (16.4%) | — | — | — | — | — | |
| (C72.5) Cranial nerve, NOS | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| (C72.9) Nervous system, NOS | — | — | — | — | — | 3 (1.1%) | — | — | — | 1 (0.3%) | — | — | — | 1 (0.5%) | — | — | |
| (C75.1) Pituitary gland | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| (C75.2) Craniopharyngeal duct | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| (C75.3) Pineal gland | — | — | — | — | — | — | — | — | 1 (0.4%) | — | — | — | — | — | — | — | |
| (IIIe) Other Specified Intracranial and Intraspinal Neoplasms | (IIIf) Unspecified Intracranial and Intraspinal Neoplasms | (Xa) Intracranial and Intraspinal Germ Cell Tumors | |||||||||||||||
| Malignant | Nonmalignant | Malignant | Nonmalignant | Malignant | |||||||||||||
| 1990-1999 | 2000-2009 | 2010-2017 | 2000-2009 | 2010-2017 | 1990-1999 | 2000-2009 | 2010- 2017 | 2000-2009 | 2010-2017 | 1990-1999 | 2000-2009 | 2010-2017 | |||||
| (N = 9) | (N = 16) | (N = 18) | (N = 275) | (N = 269) | (N = 68) | (N = 29) | (N = 64) | (N = 27) | (N = 25) | (N = 51) | (N = 41) | (N = 34) | |||||
| (C70.0) Cerebral meninges | 3 (33.3%) | 3 (18.8%) | 2 (11.1%) | 24 (8.7%) | 10 (3.7%) | — | — | — | — | — | — | — | — | ||||
| (C70.1) Spinal meninges | — | — | — | 3 (1.1%) | 4 (1.5%) | — | — | — | — | — | — | — | — | ||||
| (C70.9) Meninges, NOS | — | — | — | 1 (0.4%) | — | — | — | — | — | — | — | — | — | ||||
| (C71.0) Cerebrum | — | 2 (12.5%) | — | 3 (1.1%) | 3 (1.1%) | 6 (8.8%) | 2 (6.9%) | 8 (12.5%) | 4 (14.8%) | 3 (12.0%) | 1 (2.0%) | 3 (7.3%) | 2 (5.9%) | ||||
| (C71.1) Frontal lobe | — | 1 (6.2%) | 1 (5.6%) | 20 (7.3%) | 16 (5.9%) | — | 4 (13.8%) | 2 (3.1%) | 4 (14.8%) | — | 1 (2.0%) | 1 (2.4%) | — | ||||
| (C71.2) Temporal lobe | — | 1 (6.2%) | 2 (11.1%) | 45 (16.4%) | 49 (18.2%) | — | 1 (3.4%) | 6 (9.4%) | 1 (3.7%) | 6 (24.0%) | — | — | — | ||||
| (C71.3) Parietal lobe | — | — | 2 (11.1%) | 7 (2.5%) | 11 (4.1%) | — | — | 1 (1.6%) | 1 (3.7%) | 1 (4.0%) | — | — | — | ||||
| (C71.4) Occipital lobe | 1 (11.1%) | — | — | 4 (1.5%) | 5 (1.9%) | 1 (1.5%) | 1 (3.4%) | — | — | — | — | — | — | ||||
| (C71.5) Ventricle, NOS | — | — | — | 5 (1.8%) | 4 (1.5%) | — | 1 (3.4%) | 3 (4.7%) | 1 (3.7%) | 3 (12.0%) | 12 (23.5%) | 8 (19.5%) | 7 (20.6%) | ||||
| (C71.6) Cerebellum, NOS | — | — | — | 3 (1.1%) | 3 (1.1%) | 3 (4.4%) | 2 (6.9%) | 3 (4.7%) | 1 (3.7%) | 2 (8.0%) | 1 (2.0%) | — | — | ||||
| (C71.7) Brain stem | — | — | — | 2 (0.7%) | 3 (1.1%) | 40 (58.8%) | 8 (27.6%) | 3 (4.7%) | 2 (7.4%) | 2 (8.0%) | 1 (2.0%) | — | 2 (5.9%) | ||||
| (C71.8) Overlapping lesion of brain | — | 1 (6.2%) | 1 (5.6%) | 9 (3.3%) | 13 (4.8%) | 5 (7.4%) | — | 1 (1.6%) | 2 (7.4%) | 1 (4.0%) | 2 (3.9%) | 2 (4.9%) | 2 (5.9%) | ||||
| (C71.9) Brain, NOS | — | — | — | 2 (0.7%) | 3 (1.1%) | 4 (5.9%) | 5 (17.2%) | 7 (10.9%) | 1 (3.7%) | 2 (8.0%) | 9 (17.6%) | 6 (14.6%) | 1 (2.9%) | ||||
| (C72.0) Spinal cord | — | — | — | 3 (1.1%) | 5 (1.9%) | 1 (1.5%) | — | 1 (1.6%) | — | — | — | — | — | ||||
| (C72.1) Cauda equina | — | — | — | — | — | — | — | — | — | — | — | — | — | ||||
| (C72.3) Optic nerve | — | — | — | 2 (0.7%) | — | 3 (4.4%) | 2 (6.9%) | 27 (42.2%) | 3 (11.1%) | 3 (12.0%) | — | — | — | ||||
| (C72.5) Cranial nerve, NOS | — | — | — | — | — | 1 (1.5%) | — | — | 1 (3.7%) | — | — | — | — | ||||
| (C72.9) Nervous system, NOS | — | — | — | — | — | — | 1 (3.4%) | — | 2 (7.4%) | 1 (4.0%) | — | 1 (2.4%) | — | ||||
| (C75.1) Pituitary gland | — | — | — | 73 (26.5%) | 75 (27.9%) | — | 1 (3.4%) | — | 2 (7.4%) | — | 3 (5.9%) | 4 (9.8%) | 3 (8.8%) | ||||
| (C75.2) Craniopharyngeal duct | — | — | — | 67 (24.4%) | 64 (23.8%) | — | — | — | — | 1 (4.0%) | — | — | — | ||||
| (C75.3) Pineal gland | 5 (55.6%) | 8 (50.0%) | 10 (55.6%) | 2 (0.7%) | 1 (0.4%) | 4 (5.9%) | 1 (3.4%) | 2 (3.1%) | 2 (7.4%) | — | 21 (41.2%) | 16 (39.0%) | 17 (50.0%) |
Nonmalignant tumors were registered since the year 2000.